RPID Valuation
Rapid Micro Biosystems Inc
$
2.910
- Overview
- Forecast
- Valuation
- Earnings
RPID Relative Valuation
RPID's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RPID is overvalued; if below, it's undervalued.
Historical Valuation
Rapid Micro Biosystems Inc (RPID) is now in the Overvalued zone, suggesting that its current forward PS ratio of 4.19 is considered Overvalued compared with the five-year average of -3.29. The fair price of Rapid Micro Biosystems Inc (RPID) is between 1.17 to 2.53 according to relative valuation methord. Compared to the current price of 2.68 USD , Rapid Micro Biosystems Inc is Overvalued By 5.94%.
Relative Value
Fair Zone
1.17-2.53
Current Price：2.68
5.94%
Overvalued
-2.86
PE
1Y
3Y
5Y
Trailing
Forward
-2.86
EV/EBITDA
Rapid Micro Biosystems Inc. (RPID) has a current EV/EBITDA of -2.86. The 5-year average EV/EBITDA is -1.93. The thresholds are as follows: Strongly Undervalued below -13.96, Undervalued between -13.96 and -7.94, Fairly Valued between 4.09 and -7.94, Overvalued between 4.09 and 10.10, and Strongly Overvalued above 10.10. The current Forward EV/EBITDA of -2.86 falls within the Historic Trend Line -Fairly Valued range.
-2.71
EV/EBIT
Rapid Micro Biosystems Inc. (RPID) has a current EV/EBIT of -2.71. The 5-year average EV/EBIT is -1.72. The thresholds are as follows: Strongly Undervalued below -12.53, Undervalued between -12.53 and -7.13, Fairly Valued between 3.69 and -7.13, Overvalued between 3.69 and 9.10, and Strongly Overvalued above 9.10. The current Forward EV/EBIT of -2.71 falls within the Historic Trend Line -Fairly Valued range.
4.19
PS
Rapid Micro Biosystems Inc. (RPID) has a current PS of 4.19. The 5-year average PS is 6.56. The thresholds are as follows: Strongly Undervalued below -10.13, Undervalued between -10.13 and -1.78, Fairly Valued between 14.90 and -1.78, Overvalued between 14.90 and 23.24, and Strongly Overvalued above 23.24. The current Forward PS of 4.19 falls within the Historic Trend Line -Fairly Valued range.
-4.46
P/OCF
Rapid Micro Biosystems Inc. (RPID) has a current P/OCF of -4.46. The 5-year average P/OCF is -3.44. The thresholds are as follows: Strongly Undervalued below -12.42, Undervalued between -12.42 and -7.93, Fairly Valued between 1.04 and -7.93, Overvalued between 1.04 and 5.53, and Strongly Overvalued above 5.53. The current Forward P/OCF of -4.46 falls within the Historic Trend Line -Fairly Valued range.
-4.37
P/FCF
Rapid Micro Biosystems Inc. (RPID) has a current P/FCF of -4.37. The 5-year average P/FCF is -3.10. The thresholds are as follows: Strongly Undervalued below -12.38, Undervalued between -12.38 and -7.74, Fairly Valued between 1.54 and -7.74, Overvalued between 1.54 and 6.18, and Strongly Overvalued above 6.18. The current Forward P/FCF of -4.37 falls within the Historic Trend Line -Fairly Valued range.
Rapid Micro Biosystems Inc (RPID) has a current Price-to-Book (P/B) ratio of 1.79. Compared to its 3-year average P/B ratio of 0.64 , the current P/B ratio is approximately 177.42% higher. Relative to its 5-year average P/B ratio of 0.81, the current P/B ratio is about 120.41% higher. Rapid Micro Biosystems Inc (RPID) has a Forward Free Cash Flow (FCF) yield of approximately -27.15%. Compared to its 3-year average FCF yield of -100.33%, the current FCF yield is approximately -72.94% lower. Relative to its 5-year average FCF yield of -78.65% , the current FCF yield is about -65.48% lower.
1.79
P/B
Median3y
0.64
Median5y
0.81
-27.15
FCF Yield
Median3y
-100.33
Median5y
-78.65
Competitors Valuation Multiple
The average P/S ratio for RPID's competitors is 3.21, providing a benchmark for relative valuation. Rapid Micro Biosystems Inc Corp (RPID) exhibits a P/S ratio of 4.19, which is 30.62% above the industry average. Given its robust revenue growth of 9.73%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
RPID.O
Rapid Micro Biosystems Inc
4.19
Average P/S: 3.21
9.73%
117.47M
CMT.A
Core Molding Technologies Inc
0.52
-10.71%
146.83M
TAYD.O
Taylor Devices Inc
2.76
-13.79%
136.95M
HURC.O
Hurco Companies Inc
Loss
-9.53%
122.52M
KULR.A
KULR Technology Group Inc
8.56
39.99%
212.00M
MTEN.O
Mingteng International Corp Inc
Loss
102.12M
Performance Decomposition
1Y
3Y
5Y
Market capitalization of RPID increased by 215.29% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.82 to -2.62.
The secondary factor is the Revenue Growth, contributed 9.73%to the performance.
Overall, the performance of RPID in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
EMCG
Embrace Change Acquisition Corp
13.670
USD
+2.47%
MAIA
Maia Biotechnology Inc
1.600
USD
+1.91%
AP
Ampco-Pittsburgh Corp
3.210
USD
-5.59%
SPRU
Spruce Power Holding Corp
1.420
USD
+2.90%
ICAD
ICAD Inc
3.870
USD
+3.62%
PVL
Permianville Royalty Trust
1.860
USD
+0.54%
OVID
Ovid Therapeutics Inc
0.858
USD
+56.86%
OTLK
Outlook Therapeutics Inc
2.130
USD
+1.91%
FTCI
FTC Solar Inc
4.810
USD
0.00%
GROV
Grove Collaborative Holdings Inc
1.470
USD
-0.68%
FAQ
Is Rapid Micro Biosystems Inc (RPID) currently overvalued or undervalued?
Rapid Micro Biosystems Inc (RPID) is now in the Overvalued zone, suggesting that its current forward PS ratio of 4.19 is considered Overvalued compared with the five-year average of -3.29. The fair price of Rapid Micro Biosystems Inc (RPID) is between 1.17 to 2.53 according to relative valuation methord. Compared to the current price of 2.68 USD , Rapid Micro Biosystems Inc is Overvalued By 5.94% .
What is Rapid Micro Biosystems Inc (RPID) fair value?
How does RPID's valuation metrics compare to the industry average?
What is the current P/B ratio for Rapid Micro Biosystems Inc (RPID) as of Aug 13 2025?
What is the current FCF Yield for Rapid Micro Biosystems Inc (RPID) as of Aug 13 2025?
What is the current Forward P/E ratio for Rapid Micro Biosystems Inc (RPID) as of Aug 13 2025?